SCHEMBL19475359

SCHEMBL19475359

Cc1ccc2nc(-c3cccnc3)cc(C(=O)Nc3cc(C)on3)c2c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 8/20 0.69
ALDH1A1 P00352 8/20 0.69
KDM4E B2RXH2 7/20 0.69
TSHR P16473 6/20 0.69
HSD17B10 Q99714 6/20 0.69
MAPT P10636 6/20 0.69
USP2 O75604 4/20 0.69
GAA P10253 3/20 0.69
NPSR1 Q6W5P4 3/20 0.67
L3MBTL1 Q9Y468 1/20 0.67
MEN1 O00255 6/20 0.64
KMT2A Q03164 6/20 0.64
CYP2C9 P11712 3/20 0.64
CYP3A4 P08684 2/20 0.64
CYP2C19 P33261 2/20 0.64
LMNA P02545 4/20 0.61
POLB P06746 2/20 0.58
CYP1A2 P05177 1/20 0.58
GLA P06280 1/20 0.57
HTT P42858 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18320684 0.80 KDM4E (0.78) ALDH1A1KDM4EHSD17B10MAPTGAA
SCHEMBL17308325 0.78 KMT2A (0.74) ALDH1A1KDM4EHSD17B10MAPTGAA
SCHEMBL17681390 0.78 MEN1 (1.00) HPGDALDH1A1KDM4ETSHRHSD17B10
SCHEMBL13912444 0.75 CYP3A4 (0.77) HPGDALDH1A1KDM4EHSD17B10MAPT
SCHEMBL22573737 0.74 KDM4E (0.59) HPGDALDH1A1KDM4ETSHRHSD17B10
SCHEMBL15931846 0.73 MCL1 (0.78)
SCHEMBL13253443 0.72 PTGER4 (0.69) ALDH1A1KDM4EHSD17B10MAPTL3MBTL1
SCHEMBL13253446 0.70 CYP3A4 (0.66) ALDH1A1KDM4EHSD17B10MAPTL3MBTL1
SCHEMBL18320574 0.70 SLC2A1 (0.72) MEN1KMT2ACYP2C9CYP3A4CYP2C19
SCHEMBL12487565 0.69 MCL1 (1.00) HPGDALDH1A1KDM4ETSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190194136-A1 QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF UNIV NEW YORK (US) 2019-06-27 US claimed
WO-2017184547-A1 QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF NEW YORK UNIVERSITY (US) 2017-10-26 WO claimed
US-11192859-B2 Quinoline compounds as modulators of RAGE activity and uses thereof UNIV NEW YORK (US) 2021-12-07 US disclosed
US-11192859-B2 Quinoline compounds as modulators of RAGE activity and uses thereof UNIV NEW YORK (US) 2021-12-07 US disclosed
US-20190194136-A1 QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF UNIV NEW YORK (US) 2019-06-27 US disclosed
US-20190194136-A1 QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF UNIV NEW YORK (US) 2019-06-27 US disclosed
WO-2017184547-A1 QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF NEW YORK UNIVERSITY (US) 2017-10-26 WO disclosed
WO-2017184547-A1 QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF NEW YORK UNIVERSITY (US) 2017-10-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190194136-A1 QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF AGER, HMGB1, GPR119 HPGD 1470/4885ALDH1A1 1885/4885KDM4E 2758/4885
US-11192859-B2 Quinoline compounds as modulators of RAGE activity and uses thereof AGER, HMGB1, GPR119 HPGD 1470/4885ALDH1A1 1885/4885KDM4E 2758/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.